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Abstract
Background: The complement system is one of the important contributing factors in the development of antineutrophil
cytoplasmic antibody (ANCA)-associated vasculitis (AAV). C5a and the neutrophil C5a receptor play a central role in
antineutrophil cytoplasmic antibody (ANCA)-mediated neutrophil recruitment and activation. The current study further
investigated the signaling pathways of C5a-mediated priming of human neutrophils for ANCA-induced neutrophil
activation.
Methodology/Principal Findings: The effects of the p38 mitogen-activated protein kinase (p38MAPK) inhibitor (SB202190),
extracellular signal-regulated kinase (ERK) inhibitor (PD98059), c-Jun N-terminal kinase (JNK) inhibitor (6o) and
phosphoinositol 3-kinase (PI3K) inhibitor (LY294002) were tested on respiratory burst and degranulation of C5a-primed
neutrophils activated with ANCA, as well as on C5a-induced increase in expression of membrane-bound PR3 (mPR3) on
neutrophils. For C5a-primed neutrophils for MPO-ANCA-induced respiratory burst, the mean fluorescence intensity (MFI)
value was 254.8667.1, which decreased to 203.6660.3, 204.4636.7, 202.4649.9 and 188647.9 upon pre-incubation with
SB202190, PD98059, LY294002 and the mixture of above-mentioned three inhibitors (compared with that without
inhibitors, P,0.01, P,0.05, P,0.01 and P,0.05), respectively. For PR3-ANCA-positive IgG, the MFI value increased in C5a-
primed neutrophils, which decreased upon pre-incubation with above-mentioned inhibitors. The lactoferrin concentration
increased in C5a-primed neutrophils induced by MPO or PR3-ANCA-positive IgG supernatant and decreased upon pre-
incubation with above-mentioned three inhibitors. mPR3 expression increased from 923.36182.4 in untreated cells to
1278.36299.3 after C5a treatment and decreased to 1069.96188.9, 11006238.2, 1092.36231.8 and 1053.96200.3 by
SB202190, PD98059, LY294002 and the mixture of above-mentioned three inhibitors (compared with that without
inhibitors, P,0.01, P,0.05, P,0.01 and P,0.01), respectively.
Conclusions/Significance: Activation of p38MAPK, ERK and PI3K are important steps in the translocation of ANCA antigens
and C5a-induced activation of neutrophils by ANCA.
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Introduction
Antineutrophil cytoplasmic antibody (ANCA)-associated vascu-
litis (AAV) comprises granulomatosis with polyangiitis (GPA,
previously named Wegener’s granulomatosis), microscopic poly-
angiitis (MPA) and Churg-Strauss syndrome (CSS). [1]. ANCAs
are the serological hallmarks for the above-mentioned primary
small vessel vasculitis. Proteinase 3 (PR3) and myeloperoxidase
(MPO) are the two most important target antigens of ANCA in
AAV.
Increasing evidences suggest that ANCA-induced neutrophil
activation plays an important role in the pathogenesis of AAV. In
vitro, ANCAs activate primed neutrophils to undergo a respiratory
burst and degranulation, which may play a direct pathogenic role
in vasculitic lesion development [2–6]. In an anti-MPO antibody-
induced mouse vasculitis model [7], ANCA and neutrophils are
necessary for the initiation of glomerulonephritis [7,8]. Recent
studies, both in the mouse model and in human, suggested that
complement activation via the alternative pathway is one of the
important contributing factors in the disease development [9–11].
Schreiber et al. further found that recombinant C5a dose-
dependently primes neutrophils for ANCA-induced respiratory
burst. As such, C5a and the neutrophil C5a receptor may compose
an amplification loop and thus, plays a central role in ANCA-
mediated neutrophil recruitment and activation [12]. However,
little is known about the intracellular events that control ANCA-
mediated activation of C5a-primed neutrophils.
Mitogen-activated protein kinases (MAPK) are activated via
phosphorylation of threonine and tyrosine residues by upstream
dual-specificity kinases and provide potent inflammatory signaling
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regulated kinase (ERK), but not c-Jun N-terminal kinase (JNK),
are responsible for the tumor necrosis factor-a (TNF-a)-primed
neutrophils enabling subsequent ANCA-induced respiratory burst;
however, only p38MAPK has been demonstrated to be re-
sponsible for translocation of ANCA antigens to the cell surface
[15,16]. Phosphoinositol 3-kinase (PI3K) signaling pathway
controls various C5a-mediated effects on neutrophil and monocyte
innate immunity and exerts an overall protective effect during
experimental sepsis [17]. It has been reported that inhibition of
phosphoinositol 3 kinase-c isoform (PI3Kc) protected the mouse
from developing ANCA-associated necrotizing crescentic glomer-
ulonephritis (NCGN). Inhibition of PI3Kc blocks ANCA-induced
Akt phosphorylation in TNFa-primed neutrophils [18]. Therefore,
we hypothesized that the p38MAPK, ERK and PI3K might be
involved in C5a-primed neutrophils for ANCA-mediated re-
spiratory burst and degranulation.
Materials and Methods
Preparation of IgG
Normal IgG and ANCA-positive IgG were prepared from
plasma of normal volunteers and patients with active MPO-
ANCA- or PR3-ANCA-positive primary small vessel vasculitis,
using a High-Trap-protein G column on an AKTA-FPLC system
(GE Biosciences, South San Francisco, USA). None of these
patients had dual positivity of PR3-ANCA and MPO-ANCA.
Preparation of IgG was performed according to the methods
described previously [17,19]. We obtained written informed
consent from all participants involved in our study. The research
was in compliance of the Declaration of Helsinki and approved by
the clinical research ethics committee of the Peking University
First Hospital.
Neutrophil isolation
Neutrophils were isolated from heparinized venous blood of
healthy donors by density gradient centrifugation on Lymphoprep
(Nycomed, Oslo, Norway). Erythrocytes were lysed with ice-cold
ammonium chloride buffer, and neutrophils were washed in
Hanks balanced salt solution without Ca
2+/Mg
2+ (HBSS2/2;
Chemical reagents, Beijing, China). Neutrophils were then
suspended in HBSS with Ca
2+/Mg
2+(HBSS+/+; Chemical
reagents, Beijing, China) to a concentration of 2.5610
6 cells/ml
and used for PR3 and MPO membrane expression analysis,
respiratory burst measurements, neutrophils degranulation and
Western blot analysis [17].
P38MAPK, ERK, JNK and PI3K inhibition
Flow cytometry was used to evaluate the effect of the p38MAPK
inhibitor (SB202190) (Sigma-Aldrich, Louis, USA), the ERK
inhibitor (PD98059) (Sigma-Aldrich, Louis, USA), the JNK
inhibitor (6o) (Tocris, Louis, USA) and the PI3K inhibitor
(LY294002) (Sigma-Aldrich, Louis, USA) on PR3 and MPO
expression on neutrophils, as well as neutrophil respiratory burst,
respectively. It was found by Manthey et al. that SB202190
blocked p38MAPK at 30 mM and did not inhibit ERK and JNK
activity [20]. PD98059 was a highly selective inhibitor of ERK1
and ERK2 with the half maximal inhibitory concentration (IC50)
of 4 mM and 50 mM respectively and did not inhibit activation of
other highly related protein kinases [21–23]. 6o inhibited JNK1,
JNK2 and JNK3 at 52 nM but did not block other kinases,
including ERK2 and p38MAPK [24]. LY294002 at 50 mM
specifically abolished PI3K activity but did not inhibit other
protein kinases, including MAPK, protein kinase A, and protein
kinase C [25]. The concentration dependence of the effect of all
the inhibitors has been investigated in the above-mentioned
studies [20–25]. Therefore, we selected SB202190 at 30 mM,
PD98059 at 50 mM, 6o at 52 nM and LY294002 at 50 mM for the
experiments. Toxicity of all the inhibitors to neutrophils had been
examined by FACS using a Cell Apoptosis Detection Kit (BD
Biosciences, California, USA). Pre-incubated with inhibitors, the
proportion of living cells was higher than 90%. None of the
inhibitors in such concentrations induced a potential cell
apoptosis. Cells were pre-incubated with 30 mM SB202190, or
50 mM PD98059, or 50 mM LY294002, or the mixture of above-
mentioned three inhibitors, or 52 nM 6o, or its vehicle, DMSO, as
control, for 30 min, followed by other treatments.
Figure 1. C5a increased membrane expression of PR3 (mPR3) on neutrophils. Human neutrophils were isolated and incubated with
different concentrations of C5a for 15 min. mPR3 and mMPO were measured with flow cytometry and compared with non-stimulated cells. A: mPR3
expression compared with non-primed nertrophils (n=11). B: mMPO expression compared with non-primed neutrophils (n=11). Bars denoted
means6SD of mPR3 or mMPO expression (MFI). Differences of MFI between groups were assessed using the t test.
doi:10.1371/journal.pone.0038317.g001
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dihydrorhodamine (DHR) to rhodamine
The generation of reactive oxygen radicals was assessed using
DHR. This method was based on the fact that reactive oxygen
radicals cause an oxidation of the nonfluorescence DHR to the
green fluorescence rhodamine. Isolated neutrophils were gradually
warmed to 37uC and incubated with 0.05 mM DHR123 (Sigma-
Aldrich, Louis, USA) for 10 min at 37uC. Sodium azide (NaN3)
(2 mM) was added in order to prevent intracellular breakdown of
H2O2 by catalase. When indicated, cells were pre-incubated with
the above specific inhibitors or its vehicle, DMSO, as control for
30 min at 37uC before the priming. Then, neutrophils were
primed with 100 ng/ml C5a for 15 min at 37uC and incubated
with patient-derived ANCA-positive IgG (200 mg/ml), normal
IgG or monoclonal IgG1 antibody for 1 h at 37uC. The reaction
was stopped by addition of 1 ml of ice-cold HBSS/1% BSA.
Samples were kept on ice and analyzed using a FACScan.
Neutrophils were identified in the scatter diagram, and data were
collected from 10,000 cells per sample. The shift of green
fluorescence in the FL-1 mode was determined. For each
condition, the MFI (representing the amount of generated reactive
oxygen radicals) was reported [17,19].
Western blot analysis of phospho-p38MAPK, phospho-
ERK, phospho-JNK and phospho-Akt
Neutrophils were stimulated with C5a 100 ng/ml or buffer for
15 min followed by stimulation with MPO-ANCA-positive IgG or
PR3-ANCA-positive IgG, normal IgG or buffer control for 1 h,
respectively. Samples were harvested and cell lysates were
prepared by resuspending 1610
6 cells in 100 ml of ice-cold lysing
solution (1:100 phosphatase inhibitor). Samples were stored for
20 min on ice and centrifuged at 12,000 rpm for 5 min at 4uC.
Supernatant was collected and protein concentration was mea-
sured. Samples were incubated for 5 min at 95uC in loading buffer
(250 mM Tris-HCl [pH 6.8] with 4% sodium dodecyl sulfate,
20% glycerol, 0.01% bromphenol blue, 6% b-mercaptoethanol)
and 50 mg of protein per lane were loaded on 10% sodium dodecyl
sulfate-polyacrylamide gel, electrophoresed, and blotted onto
nitrocellulose membrane by semidry equipment. Membrane was
blocked in 5% BSA/0.05% Tween 20/tris-buffered saline (TBST)
1 h at room temperature. Phosphotyrosine was detected using
specific monoclonal rabbit antibodies to phospho-p38MAPK,
phospho-ERK, phospho-JNK and phospho-Akt (CST, Beverly,
MA, USA), respectively (1:1,000 dilution, 1:2,000 dilution, 1:1,000
dilution and 1:2,000 dilution, respectively). Total protein was
determined using specific monoclonal mouse antibodies to
p38MAPK, ERK, JNK and Akt (CST, Beverly, MA, USA),
respectively (1:1,000 dilution, respectively). The nitrocellulose
membrane was incubated overnight at 4uC with gentle agitation,
followed by three washes with TBST for 10 min each time. The
strips were then incubated with peroxidase-conjugated affinity-
purified goat anti-mouse IgG or goat anti-rabbit IgG (Sigma-
Aldrich, Louis, USA) diluted at 1:10,000 with TBST/5%BSA for
1 h at room temperature with gentle agitation. Finally, they were
revealed on autoradiographic film using ECL Plus Western
Blotting Detection System (GE Healthcare, Piscataway, NJ).
Protein levels were quantified using ImageJ software (National
Institutes of Health, Bethesda, MD) [26].
ANCAs activated C5a-primed neutrophils degranulation
Lactoferrin, an iron binding multifunctional glycoprotein that
was an abundant component of the specific granules of neutrophils
[27,28], was considered as a biomarker of neutrophil degranula-
tion [29,30]. Neutrophils were stimulated with C5a 100 ng/ml or
buffer for 15 min followed by stimulation with MPO-ANCA-
positive IgG or PR3-ANCA-positive IgG, normal IgG or buffer
control for 1 h, respectively. Cells were pre-incubated with the
above specific inhibitors or its vehicle, DMSO, as control for
30 min at 37uC before the priming. Lactoferrin in the neutrophils
supernatant, as a measure of neutrophil degranulation, were tested
by ELISA using a commercial kit (USCNK, China). The ELISA
procedure of measuring lactoferrin was as described previously
[31]. In brief, the microtiter plate was pre-coated with a mono-
clonal antibody specific to lactoferrin. Supernatant of neutrophils
degranulation reaction at dilutions of 1:500 and standards were
then added to the appropriate microtiter plate wells with a biotin-
conjugated polyclonal antibody preparation specific for lactoferrin.
Next, avidin conjugated horseradish peroxidase (HRP) was added
to each microplate well and incubated. Then a tetramethylbenzi-
dine (TMB) substrate solution was added to each well. Only those
wells that contained lactoferrin, the biotin-conjugated antibodies
and enzyme-conjugated avidin would exhibit a change in color.
The enzyme-substrate reaction was terminated by the addition of
a sulphuric acid solution and the color change was measured
spectrophotometrically at a wave-length of 450 nm610 nm. The
concentrations of lactoferrin in the samples were then determined
by comparing the OD value of the samples to the standard curve.
The inhibition rate was calculated according to the following
formula:
Inhibition rate= (MFIDMSO+C5a+MPO/PR3-ANCA-MFISB/PD/
LY+C5a+MPO/PR3-ANCA)/
(MFIDMSO+C5a+MPO/PR3-ANCA -MFIDMSO)6100%
Membrane expression of PR3 and MPO on neutrophils
after priming
Flow cytometry was used to evaluate PR3 and MPO expression
on neutrophils. Cells were incubated with C5a (10, 100, 500 and
1000 ng/ml) (Biovision, San Francisco, USA) or buffer control for
15 min at 37uC. All further steps were performed on ice and
washing steps were carried out using HBSS+/+containing 1%
bovine serum albumin (BSA). Neutrophils were incubated with
0.5 mg/ml heat-aggregated goat IgG for 15 min to saturate Fcc
receptors. Next, cells were stained with a saturating dose of mouse
monoclonal IgG1 antibody directed against human PR3 or MPO
(Abcam, Cambridge, UK) or with an irrelevant IgG1 control
antibody (Biolegend, California, USA) for 30 min. Neutrophils
were then incubated with phycoerythrin (PE)-conjugated goat
anti-mouse antibody (Abcam, Cambridge, UK) in the presence of
0.5 mg/ml heat-aggregated goat IgG. Fluorescence intensity of PE
was analyzed using flow cytometry assessment of ANCA-antigen
expression. Samples were analyzed using a FACScan (Becton
Dickinson, Germany). Neutrophils were identified in the scatter
diagram, and data were collected from 10,000 cells per sample.
The level of PR3- or MPO-expression was calculated as MFI of
specific binding of the isotype control antibody. For the inhibition
test, cells were pre-incubated with 30 mM SB202190, or 50 mM
PD98059, or 50 mM LY294002, or the mixture of above-
mentioned three inhibitors, or 52 nM 6o, or its vehicle, as control,
for 30 min on ice, followed by other treatments [17].
Statistical analysis
Shapiro-Wilk test was used to examine whether the data was
normally distributed. Quantitative data were expressed as
means6SD (for data that were normally distributed) or median
and range (for data that were not normally distributed).
Differences of quantitative parameters between groups were
assessed using the t test (for data that were normally distributed)
C5a-Mediated Neutrophils Activation
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distributed) as appropriate. Differences were considered significant
when P,0.05. Analysis was performed with SPSS statistical
software package (version 13.0, Chicago, IL, USA).
Results
C5a increased expression of membrane-bound PR3
(mPR3) on neutrophils
Expression of mPR3 on neutrophils of 11 healthy donors was
analyzed. Neutrophils were incubated with different concentra-
tions of C5a (10, 100, 500 and 1000 ng/ml), and mPR3 expression
Figure 2. Neutrophil respiratory burst induced by patient-derived MPO-ANCA-positive IgG or PR3-ANCA-positive IgG in C5a-
primed cells. Neutrophil respiratory burst induced by patient-derived MPO-ANCA-positive IgG (A) or PR3-ANCA-positive IgG (B) was measured by
conversion of dihydrorhodamine-123 (DHR-123) to rhodamine-123 in C5a-primed cells in the presence and absence of SB202190, PD98059, LY294002
or the mixture of above-mentioned three inhibitors, respectively. Differences of MFI between groups were assessed using the paired t test. C–H were
representative histograms showing that MPO-ANCA-positive IgG and PR3-ANCA-positive IgG induced respiratory burst in C5a-primed neutrophils
and that inhibition of p38MAPK, ERK and PI3K reduced the ANCA-induced respiratory burst. Bars represent mean6SD of 5 MPO-ANCA-positive IgG
and 3 PR3-ANCA-positive IgG preparations, each measured on neutrophils of 10 independent experiments and donors.
doi:10.1371/journal.pone.0038317.g002
Figure 3. Western blot analysis for phospho-p38MAPK, phospho-ERK and phospho-Akt. Neutrophils were stimulated with C5a 100 ng/ml
or buffer for 15 min followed by stimulation with normal IgG, MPO-ANCA-positive IgG or PR3-ANCA-positive IgG, and buffer control, respectively.
Samples were harvested and phospho-p38MAPK (pp38, A), phospho-ERK (pERK, B) and phospho-Akt (pAkt, C), were determined by immunoblotting.
A representative example of 4 independent experiments is shown. GAPDH is shown as loading control. 0: blank, 1: C5a+isotype control; 2: C5a+ANCA-
positive IgG. The corresponding densitometric analysis was shown in D for phosphorylated protein relative to total protein and E for total protein
relative to GAPDH (n=4). Differences of optical density between groups were assessed using the t test.
doi:10.1371/journal.pone.0038317.g003
C5a-Mediated Neutrophils Activation
PLoS ONE | www.plosone.org 5 May 2012 | Volume 7 | Issue 5 | e38317was determined by flow cytometry. The level of mPR3 expression
on neutrophils increased dose-dependently (mPR3 expression on
neutrophils were 986.96220.4, 1001.16202.1, 11696186.9,
12136187.5, 1335.26217.63, for 0, 10, 100, 500 and 1000 ng/
ml C5a, respectively, expressed as MFI). Comparing with non-
primed neutrophils, the level of mPR3 expression was significantly
higher on neutrophils primed with C5a at concentrations of 100,
500 and 1000 ng/ml (P,0.001, t-test; P,0.001, t-test; P,0.001, t-
test), respectively. The level of membrane-bound MPO (mMPO)
expression on neutrophils were 993.3691.3, 1055.56178.8,
1060.36172, 1062.26201.7, 1063.56200.1, for 0, 10, 100, 500
and 1000 ng/ml C5a, respectively, (p.0.05, t-test, compared with
non-primed neutrophils, Figure 1). Increases in membrane-bound
PR3 expression were much stronger during neutrophils priming
compared with mMPO.
P38MAPK, ERK and PI3K pathway inhibitors blocked C5a-
primed neutrophils for ANCA-induced respiratory burst
We studied whether C5a primed neutrophils for ANCA-
induced respiratory burst. ANCAs-postive IgG were prepared
from 5 patients with active MPO-ANCA-positive vasculitis and 3
patients with active PR3-ANCA-positive vasculitis, respectively.
Based on the observation described above that C5a at a concen-
tration of 100 ng/ml significantly increased mPR3 expression on
neutrophils, this concentration of C5a was employed for testing
ANCA-induced respiratory burst. Compared with non-primed
neutrophils, the MFI value increased significantly in C5a-primed
neutrophils activated with PR3-ANCA-positive IgG and MPO-
ANCA-positive IgG (314663.1 vs. 180.2612.9, P,0.01;
254.8667.1 vs. 164.4651.3, P,0.05, t-test, respectively)
(Figure 2). No obvious respiratory burst activity was observed
with C5a or ANCA-positive IgG alone (Figure 2). We next
investigated whether C5a-primed neutrophils for ANCA-induced
respiratory burst were dependent on activation of the p38MAPK,
ERK, JNK and PI3K pathways. Neutrophils were pre-incubated
with the above signal transduction inhibitors before the priming
with C5a and the subsequent stimulation with ANCA. We used
mAb to MPO or PR3 instead of human ANCA-positive IgG
preparations for comparison. Pre-incubation of neutrophils with
the p38MAPK inhibitor (SB202190), ERK inhibitor (PD98059),
PI3K inhibitor (LY294002), and the mixture of above-mentioned
three inhibitors decreased oxygen radical production in C5a
primed neutrophils induced by ANCA-positive IgG from patients.
Pre-incubation of neutrophils with the JNK inhibitor (6o) did not
decrease oxygen radical production in C5a primed neutrophils
induced by ANCA-positive IgG from patients (data not shown). In
C5a-primed neutrophils, subsequently activating with MPO-
ANCA-positive IgG, the MFI value was 254.8667.1, which
decreased to 203.6660.3, 204.4636.7, 202.4649.9 and
188647.9 upon pre-incubation with SB202190, PD98059,
LY294002 and the mixture of above-mentioned three inhibitors
(compared with that without inhibitors, P,0.01, P,0.05, P,0.01
and P,0.05, t-test), respectively. For PR3-ANCA-positive IgG,
the MFI value was 314663.1 in C5a-primed neutrophils, which
decreased to 251685.2, 260.2689.9, 255.8698.9 and
222.6676.3 upon pre-incubation with SB202190, PD98059,
LY294002 and the mixture of above-mentioned three inhibitors
(compared with that without inhibitors, P,0.05, P,0.05, P,0.05
and P,0.01, t-test), respectively (Figure 2).
Figure 4. P38MAPK, ERK and PI3K pathway inhibitors block C5a-primed neutrophils for ANCA-induced degranulation. ANCA-
induced neutrophil degranulation was determined by measuring the lactoferrin concentrations in the supernatant of neutrophil degranulation
reaction. Inhibition of p38MAPK, ERK and PI3K reduced ANCA-induced lactoferrin release. Bars represent mean6SD of 3 MPO-ANCA and 3 PR3-ANCA
preparations, measured on neutrophils of 4 donors. T test was used to compare concentration of lactoferrin between groups.
doi:10.1371/journal.pone.0038317.g004
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ERK, phospho-JNK and phospho-Akt in C5a-primed
neutrophils activated by ANCA
Western blot analysis was performed to study tyrosine
phosphorylation of p38MAPK, ERK, JNK and Akt, respectively.
Using monoclonal antibodies that detect the phosphorylated forms
of each kinase, we analyzed the effect of C5a priming as well as the
effect of the subsequent MPO-ANCA-positive IgG or PR3-
ANCA-positive IgG, stimulation. Figure 3 showed a representative
Western blot analysis of phosphorylated p38MAPK, phosphory-
lated ERK, and phosphorylated Akt and the corresponding
Western blot analysis of total p38MAPK, ERK and Akt. We
observed significantly increased phosphorylation kinases by pre-
incubation with C5a or C5a plus ANCA-positive IgG. Neither
increased phosphorylation nor increased total JNK in C5a primed
neutrophils induced by PR3-ANCA-positive IgG or MPO-ANCA-
positive IgG was observed (data not shown). There are no
significant changes of total kinase by preincubation with C5a and
ANCA-positive IgG at the mRNA level (see the File S1, Table S1
and Figure S1). These data suggested an important role for the
p38MAPK, ERK and PI3K pathways in C5a-mediated priming of
neutrophils.
P38MAPK, ERK and PI3K pathway inhibitors blocked C5a-
primed neutrophils for ANCA-induced degranulation
ANCA-induced neutrophil degranulation was determined by
measuring the lactoferrin concentration in the supernatant.
Pretreatment with p38MAPK, ERK, PI3K inhibitors or the
mixture of above-mentioned three inhibitors reduced PR3-ANCA-
positive IgG-induced and MPO-ANCA-positive IgG-induced
lactoferrin release. The lactoferrin concentration increased from
356.9623.9 ng/ml in the non-primed neutrophils supernatant to
1099.8680.7 ng/ml in C5a-primed neutrophils induced by PR3-
ANCA-positive IgG supernatant (P,0.01, t-test), and decreased to
739.3618.5 ng/ml, 383.3620.4 ng/ml, 422.1652.5 ng/ml and
378669.3 ng/ml upon pre-incubation with SB202190, PD98059,
LY294002 and the mixture of above-mentioned three inhibitors
(compared with that without inhibitors, P,0.05, P,0.01, P,0.01,
and P,0.01, t-test, the inhibition rate was 48.0268.79%,
96.4761.84%, 91.4864.62% and 97.2165.97%), respectively.
In C5a-primed neutrophils induced by MPO-ANCA-positive IgG,
the lactoferrin concentration in the supernatant increased from
359.9623.9 ng/ml in untreated cells to 1007.4634.9 ng/ml
(P,0.01, t-test), which decreased to 691.7698.5 ng/ml,
427.0640.2 ng/ml, 405.5625.6 ng/ml and 395.7616.9 ng/ml
upon pre-incubation with SB202190, PD98059, LY294002 and
the mixture of above-mentioned three inhibitors (compared with
that without inhibitors, P,0.05, P,0.01, P,0.01 and P,0.01, t-
test, the inhibition rate was 49.40614.74%, 89.0064.01%,
92.9267.32% and 94.3565.95%), respectively (Figure 4). The
inhibition rate of PI3K inhibitor was significantly higher than that
of p38MAPK inhibitor in PR3-ANCA-positive IgG and MPO-
ANCA-positive IgG mediated neutrophils degranulation (P,0.05
and P,0.05, t-test, respectively). The inhibition rate of ERK
inhibitor was significantly higher than that of p38MAPK inhibitor
in PR3-ANCA-mediated neutrophils degranulation (P,0.05, t-
test). The inhibition rate of ERK inhibitor tended to be
significantly higher than that of p38MAPK inhibitor in MPO-
ANCA-mediated neutrophils degranulation (P=0.066, t-test).
Pretreatment with JNK inhibitor did not reduce PR3-ANCA-
positive IgG-induced and MPO-ANCA-positive IgG-induced
lactoferrin release (data not shown).
Effects of the p38MAPK, ERK, JNK and PI3K inhibitor on
translocation of PR3
We studied a possible mechanism by which the p38MAPK,
ERK, JNK and PI3K pathways might control ANCA-stimulated
respiratory burst in C5a-primed neutrophils. Since we previously
found increases in mPR3 expression are much stronger during
neutrophils priming compared with MPO, we only explored
whether p38MAPK, ERK, JNK or PI3K pathway controlled the
C5a-mediated translocation of PR3 to the cell surface. Using flow
cytometry, we showed parallel experiments that inhibiting signal
pathway with SB202190, PD98059, LY294002 and the mixture of
above-mentioned three inhibitors resulted in a decreased C5a-
induced translocation of PR3. mPR3 expression increased from
923.36182.4 in untreated cells to 1278.36299.3 after C5a
treatment and decreased to 1069.96188.9, 11006238.2,
1092.36231.8 and 1053.96200.3 by SB202190, PD98059,
LY294002 and the mixture of above-mentioned three inhibitors
(compared with that without inhibitors, P,0.01, P,0.05, P,0.01
and P,0.01, t-test), respectively (Figure 5). Pretreatment with JNK
inhibitor did not reduce C5a-mediated translocation of PR3 to the
cell surface (data not shown). Together, these experiments
indicated that p38MAPK, ERK and PI3K pathways controlled
the C5a-mediated translocation of PR3 from the intracellular
granules to the cell surface.
Discussion
ANCA-induced neutrophils respiratory burst is an important
contributor to the development of ANCA-associated vasculitis.
Recent studies, both in the mouse model and in human, suggested
that complement activation is involved in the pathogenesis of AAV
[9–11]. Among the complement activation products, C5a is one of
the most potent inflammatory peptide, with a broad spectrum of
functions. C5a is a strong chemoattractant for neutrophils and also
has chemotactic activity for monocytes and macrophages
(reviewed by Guo et al. [32]). C5a exerts its effects through the
high-affinity C5a receptor. Recent investigations by Schreiber et
al. demonstrated that ANCA-stimulated neutrophils activate
complement and generate C5a. In turn, C5a was found to prime
neutrophils dose-dependently for ANCA-induced respiratory burst
[12], indicating a pivotal role of C5a and its receptor on
neutrophils in disease induction. The current study confirms and
extends these observations. Schreiber et al. reported that C5a-
conditioned serum could increase mPR3 expression on neutro-
phils. Our study confirmed this observation by demonstrating that
purified recombinant C5a dose-dependently increased neutrophil
mPR3 expression. Interestingly however, both studies demon-
strated that after incubation with C5a (or C5a-conditioned serum),
increased in membrane-bound MPO expression are much lower
than membrane-bound PR3 expression. This result was in line
with some other studies [12,33–35]. Witko-Sarsat V et al [36]
found that MPO was mainly released into the extracellular
medium and PR3 was released in minute amounts into the
extracellular medium, providing additional evidence that MPO
mobilization is different from that of PR3. In the current study, the
concentrations of secreted MPO were measured in the superna-
tant of C5a-stimulated neutrophils using specific ELISA Kit. It was
found that the concentration of extracellular release of MPO from
neutrophils with C5a-priming was significantly higher than that
without C5a-priming (see the File S1).
Several signal transduction studies have been performed to
better understand how ANCAs activated neutrophils [15,16,37].
The most important finding in the current study was that
p38MAPK, ERK and PI3K inhibition blocked C5a-dependent
C5a-Mediated Neutrophils Activation
PLoS ONE | www.plosone.org 7 May 2012 | Volume 7 | Issue 5 | e38317ANCA-mediated neutrophil activation and degranulation;
p38MAPK, ERK and PI3K inhibitors blocked C5a-primed
neutrophils for ANCA-induced respiratory burst via inhibition of
ANCA target antigen translocation. These results could explain, at
least partially, the observation by van der Veen et al. that
p38MAPK inhibition had only a moderate beneficial effect on
disease severity in the mouse model of anti-MPO IgG/LPS-
induced glomerulonephritis [16].
Our results suggested that C5a-mediated neutrophil activation
were different from that TNFa-mediated. It was found by Kettritz
et al. that p38MAPK controls the translocation of ANCA antigens
to the cell surface in the TNFa-mediated priming process;
however, ERK and PI3K were not involved in this translocation
[15]. In multiple organ dysfunction syndrome (MODS), it was
found that p38MAPK, not ERK, played a major role in the C5a
enhancement of lipopolysaccharide (LPS)-induced interleukin-6
(IL-6) and TNF-a production in peripheral blood mononuclear
cells (PBMCs) [26]. The important precondition for C5a-triggered
neutrophil activation by ANCA is the accessibility of ANCA
antigens on the cell surface, signaling mechanisms involved in
priming by C5a is necessary. The interactions between C5a
receptor and related proteins on the surface of neutrophils would
determine the signal-transduction of PR3 membrane expression.
However, the C5a receptor and TNFa receptor activated different
downstream signaling molecules subsequently.
P38MAPK, ERK and PI3K inhibitors mixture blocked C5a-
primed neutrophils for ANCA-induced respiratory burst to some
extent but not completely. According to these results, we
speculated that there were other pathways involved in this process.
Utilizing small interfering RNAs to silence kinase-associated
genes holds promise in the study of the signal pathways strategy.
However, because of the difficulty to cultivate neutrophils which
were extracted from peripheral blood and the well-known short
circulatory half-life of neutrophils, it is technically difficult to use
small interfering RNAs technique to knockdown specific signaling
Figure 5. Effects of the p38MAPK inhibitor, ERK and PI3K inhibitor on translocation of PR3. A: Neutrophils were incubated with the
SB202190, PD98059, LY294002 or the inhibitors mixture or vehicle for 30 min prior to incubation with C5a (100 ng/ml). Bars represent mean6SD of
repeated measurements on neutrophils of 10 independent experiments and donors. T test was used for comparison. B-D: a representative histogram
of effects of the above inhibitors on translocation of PR3 upon C5a priming.
doi:10.1371/journal.pone.0038317.g005
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system in the current study.
In conclusion, activation of p38MAPK, ERK and PI3K were all
important steps in the translocation of ANCA antigens and
activation of neutrophils by ANCA. Inhibiting each of these
pathways resulted in decreased respiratory burst by C5a-mediated
priming. Each kinase controlled the translocation of ANCA
antigens to the cell surface. Pharmacologic blockade of
p38MAPK, ERK and PI3K might limit inflammatory damage
caused by ANCA-activated neutrophils.
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File S1 mRNA expression of p38MAPK, ERK1/2 and
PI3K in C5a-induced ANCA mediated neutrophils acti-
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Figure S1 Q-RT-PCR analysis of mRNA p38MAPK, ERK1/2
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induced ANCA mediated neutrophils. Data of 2
2DDC
T were
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